These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 26466507)

  • 1. [Individualized pharmaceutical consultations in the management of chemotherapy-induced nausea and vomiting].
    Monfort AS; Vallin S; Te Bonle FO; Camus G; Gaveau R; Bohand X
    J Pharm Belg; 2015 Jun; (2):30-6. PubMed ID: 26466507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of anti-emetic use in chemotherapy-induced nausea and vomiting in a third-world country (Lebanon).
    Zeitoun AA; Nassif JG
    J Eval Clin Pract; 2013 Feb; 19(1):68-75. PubMed ID: 21999252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and management of chemotherapy-induced nausea and vomiting.
    Moradian S; Howell D
    Int J Palliat Nurs; 2015 May; 21(5):216, 218-24. PubMed ID: 26107543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palonosetron versus other 5-HT(3) receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with cancer on chemotherapy in a hospital outpatient setting.
    Balu S; Buchner D; Craver C; Gayle J
    Clin Ther; 2011 Apr; 33(4):443-55. PubMed ID: 21635990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment.
    Bloechl-Daum B; Deuson RR; Mavros P; Hansen M; Herrstedt J
    J Clin Oncol; 2006 Sep; 24(27):4472-8. PubMed ID: 16983116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An assessment tool for chemotherapy-induced nausea and vomiting and intervention outcomes].
    Aimono Y; Suzuki S; Nemoto M; Saito Y; Aoyama Y; Joko F; Maruyama T; Kamoshida T
    Gan To Kagaku Ryoho; 2013 Dec; 40(13):2551-4. PubMed ID: 24335368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of chemotherapy-induced nausea and emesis after modern antiemetics.
    Grunberg SM; Deuson RR; Mavros P; Geling O; Hansen M; Cruciani G; Daniele B; De Pouvourville G; Rubenstein EB; Daugaard G
    Cancer; 2004 May; 100(10):2261-8. PubMed ID: 15139073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of the hospital pharmacist in the management of chemotherapy-induced nausea and vomiting].
    Breton D; Jandard V; Cauet A; Paillet M; Galvez O; Faure A; Camus G; Beltrando X; Rimlinger H; Hervouet M; Margery J; Bohand X; Vaylet F
    J Pharm Belg; 2011 Jun; (2):46-50. PubMed ID: 21823442
    [No Abstract]   [Full Text] [Related]  

  • 9. Willingness to pay to prevent chemotherapy induced nausea and vomiting among patients with breast, lung, or colorectal cancer.
    Miller PJ; Balu S; Buchner D; Walker MS; Stepanski EJ; Schwartzberg LS
    J Med Econ; 2013 Oct; 16(10):1179-89. PubMed ID: 23919632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy-induced nausea and vomiting in the treatment of gastrointestinal tumors and secondary prophylaxis with aprepitant.
    Abbrederis K; Lorenzen S; Rothling N; Ihbe-Heffinger A; Schuster T; Peschel C; Lordick F
    Onkologie; 2009 Feb; 32(1-2):30-4. PubMed ID: 19209016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of chemotherapy induced nausea and vomiting: a focus on aprepitant.
    Sankhala KK; Pandya DM; Sarantopoulos J; Soefje SA; Giles FJ; Chawla SP
    Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1607-14. PubMed ID: 19929449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical management of chemotherapy-induced nausea and vomiting.
    Wiser W; Berger A
    Oncology (Williston Park); 2005 Apr; 19(5):637-45. PubMed ID: 15945344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances and updated guidelines in the management of chemotherapy-induced nausea and vomiting.
    Schwartzberg LS; Grunberg SM; Kris MG
    Clin Adv Hematol Oncol; 2011 Nov; 9(11 Suppl 27):1-14; quiz 15-6. PubMed ID: 22362372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of oral ondansetron and dexamethasone for the prevention of acute chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy - a retrospective audit.
    Ng WL; Della-Fiorentina SA
    Eur J Cancer Care (Engl); 2010 May; 19(3):403-7. PubMed ID: 19686353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs of uncontrolled chemotherapy-induced nausea and vomiting among working-age cancer patients receiving highly or moderately emetogenic chemotherapy.
    Tina Shih YC; Xu Y; Elting LS
    Cancer; 2007 Aug; 110(3):678-85. PubMed ID: 17567835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.
    Navari RM
    J Support Oncol; 2003; 1(2):89-103. PubMed ID: 15352652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study.
    Molassiotis A; Aapro M; Dicato M; Gascon P; Novoa SA; Isambert N; Burke TA; Gu A; Roila F
    J Pain Symptom Manage; 2014 May; 47(5):839-848.e4. PubMed ID: 24075401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide.
    Shih V; Wan HS; Chan A
    Ann Pharmacother; 2009 Mar; 43(3):444-52. PubMed ID: 19193584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis.
    Slatkin NE
    J Support Oncol; 2007 May; 5(5 Suppl 3):1-9. PubMed ID: 17566383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and acceptance of a pharmacist-run tele-oncology service for chemotherapy-induced nausea and vomiting in ambulatory cancer patients.
    Yap KY; Low HX; Koh KS; Un M; Shih V; Chan A
    Telemed J E Health; 2013 May; 19(5):387-95. PubMed ID: 23531095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.